• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by SPR Therapeutics, Inc.

    SPRINT® PNS Demonstrates Robust Results in Addressing Chronic Shoulder Pain
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    Tickers SLRC
    SPR® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT® PNS System for Low Back Pain
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR Therapeutics Announces 20,000th Patient Implant of SPRINT® PNS System
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR Therapeutics Named a Top Workplace for Second Consecutive Year
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    Real-World Data from Over 6,100 Patients Corroborates Significant Pain Reduction from Prior Prospective Studies for Patients Treated with SPRINT® PNS
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SelectHealth Initiates Peripheral Nerve Stimulation (PNS) Coverage to Support Patient Need for Effective Non-opioid Pain Treatment
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022
    From SPR Therapeutics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.